Institutionelle bei Genzyme

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Massachusetts Financial Services Co - Other 20,161,134 $542,536,115
Wellington Management Company 19,571,767 $526,676,249
Citigroup Inc. 19,114,176 $514,362,476
Barclays Bank Plc 6,064,677 $163,200,458
FMR Corporation (Fidelity Management & Research Corp) 4,616,283 $124,224,175
Putnam Investment Management, Inc. 4,570,981 $123,005,098
Vanguard Group, Inc. (The) 4,056,983 $109,173,412
Fleetboston Financial Corporation 3,699,293 $99,547,974
Invesco Funds Group, Inc. 3,357,480 $90,349,786
Taunus Corporation 2,931,535 $78,887,606

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 5,500,000 $148,005,000
Vanguard Specialized-Health Care Fund 4,780,940 $128,655,095
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,786,524 $128,805,360
MFS Mid Cap Growth Fund 1,972,300 $53,074,593
Massachusetts Investors Growth Stock Fund 1,963,000 $52,824,330
Fidelity Select Portfolios - Biotechnology 1,878,300 $50,545,053
Vanguard Index 500 Fund 1,745,323 $46,966,641
College Retirement Equities Fund-Stock Account 1,620,955 $43,619,899
Eaton Vance Tax-Managed Growth Portfolio 1,616,207 $43,492,130
GCG Trust-Mid Cap Growth Series 1,364,500 $36,718,695